Physicians at Baptist Health Lexington successfully treated patients using the newest Stereotaxis advancement, the Genesis robotic magnetic navigation (RMN) system.
Electrophysiologists at the same institution became the first to use RMN to treat patients all the way back in 2003. This robotic technology could address heart rhythm disorders through a minimally invasive procedure with robotic precision. Stereotaxis now says that, with the unveiling of its Genesis system, BHL became the first in Kentucky — and one of the first in the world — to offer the latest robotic advancement to treat cardiac arrhythmias.
“Many technologies come and go, but this is an example of a system that has continued to advance due to the clinical value in enabling safe and reliable treatment,” said Dr. Gery Tomassoni, director of electrophysiology at Baptist Health Lexington.
Stereotaxis’ RMN technology combines robotic precision and safety to offer cardiac ablation in the treatment of arrhythmias. Genesis utilizes smaller magnets that rotate along their center of mass, allowing for responsiveness to physician control. The smaller system can improve the patient experience, provide greater patient access and increase lab space. Flexible, rugged robotic arms hold the agents to increase the potential range of motion and allow for wider X-ray angulation.
“Our long-term collaboration with Baptist Health Lexington has been instrumental for technical progress, scientific discovery and clinical care,” said David Fischel, chair and CEO of Stereotaxis. “We look forward to expanding the success of robotic ablation practices for patients suffering from arrhythmias in Kentucky.”
